Vaginosis Drug Market
1 Study Coverage
1.1 Vaginosis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Vaginosis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Vaginosis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaginosis Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Vaginosis Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Vaginosis Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vaginosis Drug Sales by Region
2.4.1 Global Vaginosis Drug Sales by Region (2017-2022)
2.4.2 Global Sales Vaginosis Drug by Region (2023-2028)
2.5 Global Vaginosis Drug Revenue by Region
2.5.1 Global Vaginosis Drug Revenue by Region (2017-2022)
2.5.2 Global Vaginosis Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vaginosis Drug Sales by Manufacturers
3.1.1 Global Top Vaginosis Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Vaginosis Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaginosis Drug in 2021
3.2 Global Vaginosis Drug Revenue by Manufacturers
3.2.1 Global Vaginosis Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Vaginosis Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vaginosis Drug Revenue in 2021
3.3 Global Vaginosis Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vaginosis Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaginosis Drug Sales by Type
4.1.1 Global Vaginosis Drug Historical Sales by Type (2017-2022)
4.1.2 Global Vaginosis Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Vaginosis Drug Sales Market Share by Type (2017-2028)
4.2 Global Vaginosis Drug Revenue by Type
4.2.1 Global Vaginosis Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Vaginosis Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vaginosis Drug Revenue Market Share by Type (2017-2028)
4.3 Global Vaginosis Drug Price by Type
4.3.1 Global Vaginosis Drug Price by Type (2017-2022)
4.3.2 Global Vaginosis Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vaginosis Drug Sales by Application
5.1.1 Global Vaginosis Drug Historical Sales by Application (2017-2022)
5.1.2 Global Vaginosis Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Vaginosis Drug Sales Market Share by Application (2017-2028)
5.2 Global Vaginosis Drug Revenue by Application
5.2.1 Global Vaginosis Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Vaginosis Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vaginosis Drug Revenue Market Share by Application (2017-2028)
5.3 Global Vaginosis Drug Price by Application
5.3.1 Global Vaginosis Drug Price by Application (2017-2022)
5.3.2 Global Vaginosis Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vaginosis Drug Market Size by Type
6.1.1 North America Vaginosis Drug Sales by Type (2017-2028)
6.1.2 North America Vaginosis Drug Revenue by Type (2017-2028)
6.2 North America Vaginosis Drug Market Size by Application
6.2.1 North America Vaginosis Drug Sales by Application (2017-2028)
6.2.2 North America Vaginosis Drug Revenue by Application (2017-2028)
6.3 North America Vaginosis Drug Market Size by Country
6.3.1 North America Vaginosis Drug Sales by Country (2017-2028)
6.3.2 North America Vaginosis Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vaginosis Drug Market Size by Type
7.1.1 Europe Vaginosis Drug Sales by Type (2017-2028)
7.1.2 Europe Vaginosis Drug Revenue by Type (2017-2028)
7.2 Europe Vaginosis Drug Market Size by Application
7.2.1 Europe Vaginosis Drug Sales by Application (2017-2028)
7.2.2 Europe Vaginosis Drug Revenue by Application (2017-2028)
7.3 Europe Vaginosis Drug Market Size by Country
7.3.1 Europe Vaginosis Drug Sales by Country (2017-2028)
7.3.2 Europe Vaginosis Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaginosis Drug Market Size by Type
8.1.1 Asia Pacific Vaginosis Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Vaginosis Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Vaginosis Drug Market Size by Application
8.2.1 Asia Pacific Vaginosis Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Vaginosis Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Vaginosis Drug Market Size by Region
8.3.1 Asia Pacific Vaginosis Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Vaginosis Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vaginosis Drug Market Size by Type
9.1.1 Latin America Vaginosis Drug Sales by Type (2017-2028)
9.1.2 Latin America Vaginosis Drug Revenue by Type (2017-2028)
9.2 Latin America Vaginosis Drug Market Size by Application
9.2.1 Latin America Vaginosis Drug Sales by Application (2017-2028)
9.2.2 Latin America Vaginosis Drug Revenue by Application (2017-2028)
9.3 Latin America Vaginosis Drug Market Size by Country
9.3.1 Latin America Vaginosis Drug Sales by Country (2017-2028)
9.3.2 Latin America Vaginosis Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaginosis Drug Market Size by Type
10.1.1 Middle East and Africa Vaginosis Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vaginosis Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Vaginosis Drug Market Size by Application
10.2.1 Middle East and Africa Vaginosis Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vaginosis Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Vaginosis Drug Market Size by Country
10.3.1 Middle East and Africa Vaginosis Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vaginosis Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Piramal
11.4.1 Piramal Corporation Information
11.4.2 Piramal Overview
11.4.3 Piramal Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Piramal Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Piramal Recent Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Overview
11.5.3 Abbott Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abbott Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Recent Developments
11.6 Galderma
11.6.1 Galderma Corporation Information
11.6.2 Galderma Overview
11.6.3 Galderma Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Galderma Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Galderma Recent Developments
11.7 Mission
11.7.1 Mission Corporation Information
11.7.2 Mission Overview
11.7.3 Mission Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mission Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mission Recent Developments
11.8 Alkem
11.8.1 Alkem Corporation Information
11.8.2 Alkem Overview
11.8.3 Alkem Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Alkem Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Alkem Recent Developments
11.9 Xiuzheng
11.9.1 Xiuzheng Corporation Information
11.9.2 Xiuzheng Overview
11.9.3 Xiuzheng Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Xiuzheng Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Xiuzheng Recent Developments
11.10 Teva
11.10.1 Teva Corporation Information
11.10.2 Teva Overview
11.10.3 Teva Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Recent Developments
11.11 Perrigo
11.11.1 Perrigo Corporation Information
11.11.2 Perrigo Overview
11.11.3 Perrigo Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Perrigo Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Perrigo Recent Developments
11.12 West-Ward
11.12.1 West-Ward Corporation Information
11.12.2 West-Ward Overview
11.12.3 West-Ward Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 West-Ward Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 West-Ward Recent Developments
11.13 HPGC
11.13.1 HPGC Corporation Information
11.13.2 HPGC Overview
11.13.3 HPGC Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 HPGC Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 HPGC Recent Developments
11.14 Yunnan Baiyao
11.14.1 Yunnan Baiyao Corporation Information
11.14.2 Yunnan Baiyao Overview
11.14.3 Yunnan Baiyao Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Yunnan Baiyao Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Yunnan Baiyao Recent Developments
11.15 Starpharma
11.15.1 Starpharma Corporation Information
11.15.2 Starpharma Overview
11.15.3 Starpharma Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Starpharma Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Starpharma Recent Developments
11.16 Novel
11.16.1 Novel Corporation Information
11.16.2 Novel Overview
11.16.3 Novel Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Novel Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Novel Recent Developments
11.17 Edenvridge
11.17.1 Edenvridge Corporation Information
11.17.2 Edenvridge Overview
11.17.3 Edenvridge Vaginosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Edenvridge Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Edenvridge Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaginosis Drug Industry Chain Analysis
12.2 Vaginosis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaginosis Drug Production Mode & Process
12.4 Vaginosis Drug Sales and Marketing
12.4.1 Vaginosis Drug Sales Channels
12.4.2 Vaginosis Drug Distributors
12.5 Vaginosis Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vaginosis Drug Industry Trends
13.2 Vaginosis Drug Market Drivers
13.3 Vaginosis Drug Market Challenges
13.4 Vaginosis Drug Market Restraints
14 Key Findings in The Global Vaginosis Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Vaginosis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Rx
Table 3. Major Manufacturers of OTC
Table 4. Global Vaginosis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vaginosis Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Vaginosis Drug Sales by Region (2017-2022) & (K Doses)
Table 7. Global Vaginosis Drug Sales Market Share by Region (2017-2022)
Table 8. Global Vaginosis Drug Sales by Region (2023-2028) & (K Doses)
Table 9. Global Vaginosis Drug Sales Market Share by Region (2023-2028)
Table 10. Global Vaginosis Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Vaginosis Drug Revenue Market Share by Region (2017-2022)
Table 12. Global Vaginosis Drug Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Vaginosis Drug Revenue Market Share by Region (2023-2028)
Table 14. Global Vaginosis Drug Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Vaginosis Drug Sales Share by Manufacturers (2017-2022)
Table 16. Global Vaginosis Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Vaginosis Drug Revenue Share by Manufacturers (2017-2022)
Table 18. Vaginosis Drug Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Vaginosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Vaginosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginosis Drug as of 2021)
Table 21. Vaginosis Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vaginosis Drug Product Offered
Table 23. Date of Manufacturers Enter into Vaginosis Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 26. Global Vaginosis Drug Sales by Type (2023-2028) & (K Doses)
Table 27. Global Vaginosis Drug Sales Share by Type (2017-2022)
Table 28. Global Vaginosis Drug Sales Share by Type (2023-2028)
Table 29. Global Vaginosis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Vaginosis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Vaginosis Drug Revenue Share by Type (2017-2022)
Table 32. Global Vaginosis Drug Revenue Share by Type (2023-2028)
Table 33. Vaginosis Drug Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Vaginosis Drug Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 36. Global Vaginosis Drug Sales by Application (2023-2028) & (K Doses)
Table 37. Global Vaginosis Drug Sales Share by Application (2017-2022)
Table 38. Global Vaginosis Drug Sales Share by Application (2023-2028)
Table 39. Global Vaginosis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Vaginosis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Vaginosis Drug Revenue Share by Application (2017-2022)
Table 42. Global Vaginosis Drug Revenue Share by Application (2023-2028)
Table 43. Vaginosis Drug Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Vaginosis Drug Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 46. North America Vaginosis Drug Sales by Type (2023-2028) & (K Doses)
Table 47. North America Vaginosis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Vaginosis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 50. North America Vaginosis Drug Sales by Application (2023-2028) & (K Doses)
Table 51. North America Vaginosis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Vaginosis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Vaginosis Drug Sales by Country (2017-2022) & (K Doses)
Table 54. North America Vaginosis Drug Sales by Country (2023-2028) & (K Doses)
Table 55. North America Vaginosis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Vaginosis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Vaginosis Drug Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Vaginosis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Vaginosis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Vaginosis Drug Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Vaginosis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Vaginosis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Vaginosis Drug Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Vaginosis Drug Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Vaginosis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Vaginosis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Vaginosis Drug Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Vaginosis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Vaginosis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Vaginosis Drug Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Vaginosis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Vaginosis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vaginosis Drug Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Vaginosis Drug Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Vaginosis Drug Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vaginosis Drug Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Vaginosis Drug Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Vaginosis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Vaginosis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Vaginosis Drug Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Vaginosis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Vaginosis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Vaginosis Drug Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Vaginosis Drug Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Vaginosis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Vaginosis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Vaginosis Drug Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Vaginosis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Vaginosis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Vaginosis Drug Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Vaginosis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Vaginosis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vaginosis Drug Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Vaginosis Drug Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Vaginosis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vaginosis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Major Businesses
Table 107. Bayer Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Bayer Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Bayer Recent Developments
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Pfizer Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Pfizer Recent Developments
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Major Businesses
Table 117. Sanofi Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Sanofi Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi Recent Developments
Table 120. Piramal Corporation Information
Table 121. Piramal Description and Major Businesses
Table 122. Piramal Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Piramal Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Piramal Recent Developments
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Major Businesses
Table 127. Abbott Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Abbott Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Abbott Recent Developments
Table 130. Galderma Corporation Information
Table 131. Galderma Description and Major Businesses
Table 132. Galderma Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Galderma Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Galderma Recent Developments
Table 135. Mission Corporation Information
Table 136. Mission Description and Major Businesses
Table 137. Mission Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Mission Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Mission Recent Developments
Table 140. Alkem Corporation Information
Table 141. Alkem Description and Major Businesses
Table 142. Alkem Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Alkem Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Alkem Recent Developments
Table 145. Xiuzheng Corporation Information
Table 146. Xiuzheng Description and Major Businesses
Table 147. Xiuzheng Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Xiuzheng Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Xiuzheng Recent Developments
Table 150. Teva Corporation Information
Table 151. Teva Description and Major Businesses
Table 152. Teva Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Teva Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Teva Recent Developments
Table 155. Perrigo Corporation Information
Table 156. Perrigo Description and Major Businesses
Table 157. Perrigo Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. Perrigo Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Perrigo Recent Developments
Table 160. West-Ward Corporation Information
Table 161. West-Ward Description and Major Businesses
Table 162. West-Ward Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 163. West-Ward Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. West-Ward Recent Developments
Table 165. HPGC Corporation Information
Table 166. HPGC Description and Major Businesses
Table 167. HPGC Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 168. HPGC Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. HPGC Recent Developments
Table 170. Yunnan Baiyao Corporation Information
Table 171. Yunnan Baiyao Description and Major Businesses
Table 172. Yunnan Baiyao Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 173. Yunnan Baiyao Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Yunnan Baiyao Recent Developments
Table 175. Starpharma Corporation Information
Table 176. Starpharma Description and Major Businesses
Table 177. Starpharma Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 178. Starpharma Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Starpharma Recent Developments
Table 180. Novel Corporation Information
Table 181. Novel Description and Major Businesses
Table 182. Novel Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 183. Novel Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Novel Recent Developments
Table 185. Edenvridge Corporation Information
Table 186. Edenvridge Description and Major Businesses
Table 187. Edenvridge Vaginosis Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 188. Edenvridge Vaginosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Edenvridge Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Vaginosis Drug Distributors List
Table 193. Vaginosis Drug Customers List
Table 194. Vaginosis Drug Market Trends
Table 195. Vaginosis Drug Market Drivers
Table 196. Vaginosis Drug Market Challenges
Table 197. Vaginosis Drug Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaginosis Drug Product Picture
Figure 3. Global Vaginosis Drug Market Share by Type in 2021 & 2028
Figure 3. Rx Product Picture
Figure 4. OTC Product Picture
Figure 5. Global Vaginosis Drug Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Other
Figure 9. Vaginosis Drug Report Years Considered
Figure 10. Global Vaginosis Drug Sales 2017-2028 (K Doses)
Figure 11. Global Vaginosis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Vaginosis Drug Revenue 2017-2028 (US$ Million)
Figure 13. Global Vaginosis Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Vaginosis Drug Sales Market Share by Region (2017-2022)
Figure 15. Global Vaginosis Drug Sales Market Share by Region (2023-2028)
Figure 16. North America Vaginosis Drug Sales YoY (2017-2028) & (K Doses)
Figure 17. North America Vaginosis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Vaginosis Drug Sales YoY (2017-2028) & (K Doses)
Figure 19. Europe Vaginosis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Vaginosis Drug Sales YoY (2017-2028) & (K Doses)
Figure 21. Asia-Pacific Vaginosis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Vaginosis Drug Sales YoY (2017-2028) & (K Doses)
Figure 23. Latin America Vaginosis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Vaginosis Drug Sales YoY (2017-2028) & (K Doses)
Figure 25. Middle East & Africa Vaginosis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Vaginosis Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Vaginosis Drug in the World: Market Share by Vaginosis Drug Revenue in 2021
Figure 28. Global Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Vaginosis Drug Sales Market Share by Type (2017-2028)
Figure 30. Global Vaginosis Drug Revenue Market Share by Type (2017-2028)
Figure 31. Global Vaginosis Drug Sales Market Share by Application (2017-2028)
Figure 32. Global Vaginosis Drug Revenue Market Share by Application (2017-2028)
Figure 33. North America Vaginosis Drug Sales Market Share by Type (2017-2028)
Figure 34. North America Vaginosis Drug Revenue Market Share by Type (2017-2028)
Figure 35. North America Vaginosis Drug Sales Market Share by Application (2017-2028)
Figure 36. North America Vaginosis Drug Revenue Market Share by Application (2017-2028)
Figure 37. North America Vaginosis Drug Sales Share by Country (2017-2028)
Figure 38. North America Vaginosis Drug Revenue Share by Country (2017-2028)
Figure 39. U.S. Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Vaginosis Drug Sales Market Share by Type (2017-2028)
Figure 42. Europe Vaginosis Drug Revenue Market Share by Type (2017-2028)
Figure 43. Europe Vaginosis Drug Sales Market Share by Application (2017-2028)
Figure 44. Europe Vaginosis Drug Revenue Market Share by Application (2017-2028)
Figure 45. Europe Vaginosis Drug Sales Share by Country (2017-2028)
Figure 46. Europe Vaginosis Drug Revenue Share by Country (2017-2028)
Figure 47. Germany Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 48. France Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Vaginosis Drug Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Vaginosis Drug Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Vaginosis Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Vaginosis Drug Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Vaginosis Drug Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Vaginosis Drug Revenue Share by Region (2017-2028)
Figure 58. China Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 61. India Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Vaginosis Drug Sales Market Share by Type (2017-2028)
Figure 69. Latin America Vaginosis Drug Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Vaginosis Drug Sales Market Share by Application (2017-2028)
Figure 71. Latin America Vaginosis Drug Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Vaginosis Drug Sales Share by Country (2017-2028)
Figure 73. Latin America Vaginosis Drug Revenue Share by Country (2017-2028)
Figure 74. Mexico Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Vaginosis Drug Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Vaginosis Drug Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Vaginosis Drug Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Vaginosis Drug Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Vaginosis Drug Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Vaginosis Drug Revenue Share by Country (2017-2028)
Figure 83. Turkey Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Vaginosis Drug Revenue (2017-2028) & (US$ Million)
Figure 86. Vaginosis Drug Value Chain
Figure 87. Vaginosis Drug Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
